PERBANDINGAN KINERJA KEUANGAN PERUSAHAAN FARMASI MILIK BUMN DAN SWASTA PERIODE 2016-2018
DOI:
https://doi.org/10.32529/jim.v4i2.591Kata Kunci:
Financial performance, ROE, EPS, EVAAbstrak
The purpose of this study was to determine the comparison of the financial performance of state-owned pharmaceutical companies with private-owned pharmaceutical companies and find out what factors affect differences in company performance based on analysis of profitability, market value rations and EVA. This study using a quantitative approach using a comparative descriptive method that took a sample of 4 pharmaceutical companies listed on the Stock Excahange. The data analysis technique uses a different independent sample T-test by comparing financial data from state-owned and private pharmaceutical companies in the 2016-2018 period. The results of the study show that return on equity (ROE) analysis of state-owned pharmaceutical companies is not safe because there are significant differences in the precentage above 15% and private pharmaceutical above 15%. The earning per share (EPS) analysis results of state-owned companies reached 0,35 and private pharmaceutical companies reached 50,71. As well as economic value added (EVA) analysis produces data there are differences in financial performace where the state-owned pharmaceutical companies have increased and privat pharmaceutical companies have decreased.
Referensi
Ahmad Tanzeh. 2009. Pengantar Metode Penelitian. Yogyakarta: Teras.
Doerachman, Darma, Parengkuan Tommy, and Paulina Van Rate. 2016. “Perusahaan Farmasi Yang Terdaftar Di Bursa Efek Indonesia Periode 2011-2014 Companies Listed At Indonesia Stock Exchange In 2011-2014†16 (03): 27–37.
Dorotea Noesman Riberu. 2017. “Kinerja Keuangan Perusahaan Dengan Menggunakan Rasio Keuangan Dan Konsep Ekonomic Value Added (EVA) (Studi Kasus Pada PT. Pertamina Periode 2012-2014).†Ekonomi Akuntansi 2 (1): 22.
Enniyatul Mizan. 2018. “Pengaruh Pengukuran Return On Asset, Return On Equity, Earning Per Share, Dan Ekonomic Value Added Terhadap Market Value Added.†Akuntansi Dan Investasi 3 (1): 28.
Galib, Mukhtar, Muhammad Hidayat. 2018. “Analisis Kinerja Perusahaan Dengan Menggunakan Pendekatan Balanced Scorecard Pada PT. Bosowa Propertindo.†Journal of Manajement and Buisiness 2 (1): 92–112.
Iwin Arnova. 2013. “Pengaruh Ukuran Kinerja ROA, ROE, EPS dan EVA Terhadap Return Saham†2011, .†Ekonomi Bisnis, 36–53.
Kasmir. 2009. Pengantar Manajemen Keuangan. Pertama. Jakarta.
M. Abdullah. 2014. Manajemen dan Evaluasi Kinerja Karyawan. Yogyakarta: Aswaja Pressindo.
Mardiyani, Mardiyani. 2017. “Analisis Perbandingan Kinerja Keuangan Perusahaan Farmasi Milik BUMN dan Swasta.†Jurnal Inspirasi Bisnis dan Manajemen 1 (1): 19.
Moerdiyanto. 2010. “Pengaruh Tingkat Pendidikan Manajer Terhadap Kinerja Perusahaan.†Cakrawala Pendidikan, 2–3.
Nurhidayah, Ronny Malavia Mardani, M. Agus Salim. n.d. “Analisis Perbandingan Kinerja Keuangan antara Perusahaan Farmasi Milik Pemerintah (BUMN) dengan Perusahaan Farmasi Milik Swasta Yang Terdaftar Di Bursa Efek Indonesia (BEI) Periode Tahun 2014-2016.†E – Jurnal Riset Manajemen Prodi Manajemen, 21–30.
Nurmila Dewi, Azizah Mardilla. 2016. “Pengaruh Kinerja Keuangan Terhadap Harga Saham pada Emiten Yang Tergabung dalam Jakarta Islamic Index.†Jurnal Ekonomi Dan Bisnis 16 (01).
Rahma Febriyanti. 2014. “Nalisis Pengaruh Return On Equity (ROE), Earning Per Share (EPS), Dividend Per Share (DPS) Dan Economic Value Added (EVA) Terhadap Market Value Added (MVA) pada Perusahaan Manufaktur Sektor Industri Barang Konsumsi Yang Terdapat Di Bursa Efek Indo.†Ekonomi Bisnis, 1–28.
Ratih F D Simbolon, Moch. Dzulkiron, Muhammad Saifi. 2014. “Analisis EVA (Economic Value Added) untuk Menilai Kinerja Keuangan Perusahaan (Studi Pada Perusahaan Farmasi pada Bursa Efek Indonesia Periode 2010-2012 ).†Administrasi Bisnis (JAB) 8 (1): 1–8.
Ratu, Rifany Angelia. 2016. “Analisis Perbandingan Kinerja Keuangan Pada PT. Kimia Farma Tbk, dan PT. Kalbe Farma Tbk Periode 2011-2014.†Jurnal Berkala Ilmiah Efisiensi 16 (03): 111–20.
Sampul, Gladys T P, “Perbandingan Kinerja Keuangan Perusahaan Farmasi Milik Negara dan Milik Swasta yang Terdaftar di Bursa Efek Indonesia.†Jurnal EMBA 1 (4): 359.
Saragih, Fitriani. 2017. “Kinerja Keuangan Perusahaan Pada PT. Pelabuhan Indonesia I (Persero) Medan,†57–68.
Yoga Prasetyo, Mulatsih., MM, Lasminiasih3. 2019. “Analisis Kinerja Keuangan PT. Kalbe Farma, Tbk Menggunakan Economic Value Added dan Market Value Added sebagai Tolak Ukur Investor dalam Mengambil Keputusan,†no. 1: 978–79.
